title: Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730.
abstract: Probiotic bacteria encounter various stresses after ingestion by the host, including exposure to the low pH in the stomach and bile in the small intestine. The probiotic microorganism Lactobacillus reuteri ATCC 55730 has previously been shown to survive in the human small intestine. To address how L. reuteri can resist bile stress, we performed microarray experiments to determine gene expression changes that occur when the organism is exposed to physiological concentrations of bile. A wide variety of genes that displayed differential expression in the presence of bile indicated that the cells were dealing with several types of stress, including cell envelope stress, protein denaturation, and DNA damage. Mutations in three genes were found to decrease the strain's ability to survive bile exposure: lr1864, a Clp chaperone; lr0085, a gene of unknown function; and lr1516, a putative esterase. Mutations in two genes that form an operon, lr1584 (a multidrug resistance transporter in the major facilitator superfamily) and lr1582 (unknown function), were found to impair the strain's ability to restart growth in the presence of bile. This study provides insight into the possible mechanisms that L. reuteri ATCC 55730 may use to survive and grow in the presence of bile in the small intestine.
authors.affiliation: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA.
authors.forename: Kristi
authors.initials: K
authors.lastname: Whitehead
authors.forename: James
authors.initials: J
authors.lastname: Versalovic
authors.forename: Stefan
authors.initials: S
authors.lastname: Roos
authors.forename: Robert A
authors.initials: RA
authors.lastname: Britton
mesh_terms: D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D001647:Bile Acids and Salts / Q000494:pharmacology*; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects*; D023281:Genomics / Q000379:methods; D052200:Limosilactobacillus reuteri / Q000187:drug effects* / Q000235:genetics* / Q000254:growth & development; D050296:Microbial Viability / Q000187:drug effects; D020411:Oligonucleotide Array Sequence Analysis; D019936:Probiotics / Q000378:metabolism
chemical_list: D001426:Bacterial Proteins; D001647:Bile Acids and Salts